The Cooper Companies announced financial results for the fiscal fourth quarter and full year ended October 31, 2016. Fourth quarter revenue increased 14% year-over-year to $518.7 million. Fiscal 2016 revenue increased 9% to $1,966.8 million.
Fourth quarter GAAP earnings per share (EPS) $1.23, up 48 cents or 64% from last year’s fourth quarter. Fiscal 2016 GAAP EPS $5.59, up 35% from fiscal 2015. Fourth quarter non-GAAP EPS $2.28, up 28 cents or 14% from last year’s fourth quarter. Fiscal 2016 non-GAAP EPS $8.44, up 13% from fiscal 2015.
Revenue $1,966.8 million, up 9.4% from fiscal 2015, up 7.3% pro forma.
Cash provided by operations $509.6 million and capital expenditures $152.6 million resulted in free cash flow of $357.0 million.
Commenting on the results, Robert S. Weiss, Cooper’s president and chief executive officer said, “I am pleased to report record revenue and free cash flow for the year. We accomplished this through market share gains, a successful push into the 1-Day silicone hydrogel space, growth in our Biofinity® franchise and very strong year in our CooperSurgical business. We enter fiscal 2017 with momentum and are well positioned for sustained growth in each of our businesses going forward.”
Click HERE for the full press release.
